Presentations & Publications

Presentation

A recombinant HER2/Neu expressing Listeria monocytogenes (Lm9LLO) immunotherapy delays metastatic disease and prolongs overall survival in a spontaneous canine model of osteosarcoma

SITC, November 10, 2014

STAY TUNED

Mailing List

Sign up for email alerts for Press Releases & breaking Advaxis news.

SOCIAL

Follow Us

Stay up to date on the latest events, news, and happenings on Advaxis and Immunotherapy.